Monday, April 29, 2024
HomeTagsAmendment

Amendment

AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101

AnBogen Therapeutics, a clinical-stage biotech company designing and developing precision oncology therapies to improve the life of patients, announces that U.S. Food and Drug...

Neptune Announces Amendment and Expansion of Sprout Secured Promissory Notes Led by Morgan Stanley

Neptune Wellness Solutions Inc. ("Neptune" or the "Company"), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle...

CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal

CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics